Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7274
    +0.0010 (+0.14%)
     
  • CRUDE OIL

    83.44
    +0.71 (+0.86%)
     
  • Bitcoin CAD

    87,817.88
    +531.05 (+0.61%)
     
  • CMC Crypto 200

    1,381.00
    +68.38 (+5.21%)
     
  • GOLD FUTURES

    2,403.60
    +5.60 (+0.23%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Oak Street Health (OSH) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Oak Street Health, Inc. (NYSE: OSH) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

Visit: www.hbsslaw.com/investor-fraud/OSH

Contact An Attorney Now:

OSH@hbsslaw.com

844-916-0895

Oak Street Health, Inc. (OSH) Investigation:

In the past Oak Street has repeatedly touted its “strong” growth, recently increased its FY 2021 revenue guidance, and maintained it complied with applicable federal laws and regulations.

ADVERTISEMENT

On Nov. 8, 2021, Oak Street announced its Q3 2021 financial results, which included a slight miss from the consensus loss estimate. However, the company also disclosed it received a civil investigative demand (“CID”) on Nov. 1, 2021, indicating the U.S. Department of Justice is investigating the company’s relationships with third-party marketing agents and whether the company’s provision of free transportation to federal health care beneficiaries violated the federal False Claims Act.

This news sent the price of Oak Street shares sharply lower on Nov. 9, 2021.

“We’re focused on investors’ losses and whether Oak Street may have misled investors about its compliance with the FCA and possibly overstated its revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Oak Street and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Oak Street should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email OSH@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895